PREVACID NAPRAPAC 500 (COPACKAGED) Drug Patent Profile

✉ Email this page to a colleague

When do Prevacid Naprapac 500 (copackaged) patents expire, and what generic alternatives are available?

Prevacid Naprapac 500 (copackaged) is a drug marketed by Takeda Pharms Na and is included in one NDA.

The generic ingredient in PREVACID NAPRAPAC 500 (COPACKAGED) is lansoprazole; naproxen. There are fifty-six drug master file entries for this compound. Additional details are available on the lansoprazole; naproxen profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PREVACID NAPRAPAC 500 (COPACKAGED)?
What are the global sales for PREVACID NAPRAPAC 500 (COPACKAGED)?
What is Average Wholesale Price for PREVACID NAPRAPAC 500 (COPACKAGED)?

Summary for PREVACID NAPRAPAC 500 (COPACKAGED)

US Patents:	0
Applicants:	1
NDAs:	1
DailyMed Link:	PREVACID NAPRAPAC 500 (COPACKAGED) at DailyMed

Drug patent expirations by year for PREVACID NAPRAPAC 500 (COPACKAGED)

US Patents and Regulatory Information for PREVACID NAPRAPAC 500 (COPACKAGED)

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Takeda Pharms Na	PREVACID NAPRAPAC 500 (COPACKAGED)	lansoprazole; naproxen	CAPSULE, DELAYED REL PELLETS, TABLET;ORAL	021507-004	Nov 14, 2003		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PREVACID NAPRAPAC 500 (COPACKAGED)

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Takeda Pharms Na	PREVACID NAPRAPAC 500 (COPACKAGED)	lansoprazole; naproxen	CAPSULE, DELAYED REL PELLETS, TABLET;ORAL	021507-004	Nov 14, 2003	⤷ Sign Up	⤷ Sign Up
Takeda Pharms Na	PREVACID NAPRAPAC 500 (COPACKAGED)	lansoprazole; naproxen	CAPSULE, DELAYED REL PELLETS, TABLET;ORAL	021507-004	Nov 14, 2003	⤷ Sign Up	⤷ Sign Up
Takeda Pharms Na	PREVACID NAPRAPAC 500 (COPACKAGED)	lansoprazole; naproxen	CAPSULE, DELAYED REL PELLETS, TABLET;ORAL	021507-004	Nov 14, 2003	⤷ Sign Up	⤷ Sign Up
Takeda Pharms Na	PREVACID NAPRAPAC 500 (COPACKAGED)	lansoprazole; naproxen	CAPSULE, DELAYED REL PELLETS, TABLET;ORAL	021507-004	Nov 14, 2003	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PREVACID NAPRAPAC 500 (COPACKAGED)

See the table below for patents covering PREVACID NAPRAPAC 500 (COPACKAGED) around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
South Africa	8506117		⤷ Sign Up
Germany	3780045		⤷ Sign Up
Mexico	9203043	DERIVADOS DE PIRIDINA.	⤷ Sign Up
Latvia	5775	Piridina atvasinajumi un to iegusanas panemiens	⤷ Sign Up
Hong Kong	4792	PYRIDINE DERIVATIVES AND THEIR PRODUCTION	⤷ Sign Up
Hungary	195210	PROCESS FOR PRODUCING PYRIDINE DERIVATIVES AND PHARMACEUTICAL PREPARATIONS COMPRISING THESE COMPOUNDS AS ACTIVE SUBSTANCE	⤷ Sign Up
Bulgaria	60415		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for PREVACID NAPRAPAC 500 (COPACKAGED)

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0174726	93C0021	Belgium	⤷ Sign Up	PRODUCT NAME: LANSOPRAZOLE; NAT. REG.: 150 S 539 F 4 19921119; FIRST REG.: FR 333 412.1 19901211
0174726	SPC/GB94/011	United Kingdom	⤷ Sign Up	SPC/GB94/011, EXPIRES: 20051210
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for PREVACID NAPRAPAC 500 (COPACKAGED)

Make Better Decisions: Try a trial or see plans & pricing